The update of the 2021 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Guidelines for the Treatment of Infections Caused by Multidrug-Resistant Gram-Negative Bacilli Key facts Chair(s): Mical Paul, Israel Approval date: February 2025 Expected completion: April 2026…
Get to know moreESCMID guideline ‘Selection and duration of antibiotic treatment in Infectious Aortitis (IA) and Vascular Graft and Endograft Infections (VGEI) Key facts Chair(s): Marjan Wouthuyzen-Bakker, Netherlands Approval date: February 2025 Expected completion: Comment: Last status report date: February 2026…
Get to know moreESCMID Guidelines for the diagnosis, clinical management and follow-up of patients with alveolar echinococcosis Key facts Chair(s): Beate Gruener, Germany Approval date: February 2026 Expected completion: August 2026 Last status report date: February 2026 Status Report Guideline Development Steps…
Get to know moreGuidelines in development ESCMID works throughout the year to propose and endorse quality guidelines to members and the global professional community. Below is a list of guidance documents that are currently under development. Explore the details of each guidance document and follow the evolution of…
Get to know moreGuidelines & Journals The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) considers the creation of guidelines essential to equipping healthcare professionals with the necessary tools and knowledge to integrate best clinical practices into their work. ESCMID's published…
Get to know moreVaccination of the immunocompromised host Key facts Chair(s): Olivier Epaulard, Grenoble, France Approval date: March 2023 Expected completion: May 2025 Last status report date: February 2026 Status Report Guideline Development Steps Status Guideline Group Membership Completed Establishing Guideline…
Get to know moreNomenclature, diagnosis and treatment of acute and chronic Q fever Key facts Chair(s): Chantal Rovers, Netherlands Approval date: February 2025 Expected completion: April 2027 Comment: Last status report date: February 2026 Status Report Guideline Development Steps Status Guideline Group Membership…
Get to know moreDosing of antimicrobials in patients with renal impairment with or without RRT Key facts Chair(s): Thomas Tängdén, Uppsala, Sweden Approval date: March 2023 Expected completion: April 2025 Comment: Last status report date: February 2026 Status Report Guideline Development Steps Status Guideline…
Get to know moreGroup A streptococcal infections Key facts Chair(s): Katherine Gibney, Australia Approval date: February 2026 Expected completion: August 2026 Last status report date: February 2026 Status Report Guideline Development Steps Status Guideline Group Membership Completed Establishing Guideline Group…
Get to know morePneumocystis pneumonia Key facts Chair(s): Alexandre Alanio, France Approval date: February 2026 Expected completion: August 2026 Last status report date: February 2026 Status Report Guideline Development Steps Status Guideline Group Membership Completed Establishing Guideline Group Processes…
Get to know more